News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,309 Results
Type
Article (10983)
Company Profile (55)
Press Release (288271)
Section
Business (99892)
Career Advice (686)
Deals (17846)
Drug Delivery (13)
Drug Development (30918)
Employer Resources (40)
FDA (6735)
Job Trends (6366)
News (156046)
Policy (11090)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (799)
Accelerated approval (2)
Adcomms (4)
Allergies (69)
Alliances (20722)
ALS (32)
Alzheimer's disease (474)
Antibody-drug conjugate (ADC) (22)
Approvals (6807)
Artificial intelligence (89)
Autoimmune disease (5)
Automation (5)
Bankruptcy (115)
Best Places to Work (5219)
BIOSECURE Act (1)
Biosimilars (24)
Biotechnology (55)
Bladder cancer (30)
Brain cancer (10)
Breast cancer (117)
Cancer (855)
Cardiovascular disease (38)
Career advice (588)
Career pathing (10)
CAR-T (53)
Cell therapy (163)
Cervical cancer (7)
Clinical research (25605)
Collaboration (333)
Compensation (177)
Complete response letters (4)
COVID-19 (799)
CRISPR (15)
C-suite (122)
Cystic fibrosis (32)
Data (934)
Denatured (1)
Depression (12)
Diabetes (79)
Diagnostics (2898)
Digital health (3)
Diversity, equity & inclusion (17)
Drug discovery (57)
Drug pricing (8)
Drug shortages (4)
Duchenne muscular dystrophy (24)
Earnings (44690)
Editorial (4)
Employer branding (6)
Employer resources (41)
Events (48016)
Executive appointments (381)
FDA (7215)
Featured Employer (17)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (306)
Gene editing (33)
Generative AI (9)
Gene therapy (82)
GLP-1 (181)
Government (990)
Grass and pollen (3)
Guidances (23)
Healthcare (6879)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (27)
Indications (15)
Infectious disease (836)
Inflammatory bowel disease (54)
Inflation Reduction Act (2)
Influenza (12)
Intellectual property (23)
Interviews (85)
IPO (8971)
IRA (5)
Job creations (1402)
Job search strategy (535)
Kidney cancer (7)
Labor market (6)
Layoffs (129)
Leadership (5)
Legal (2923)
Liver cancer (23)
Lung cancer (98)
Lymphoma (64)
Machine learning (1)
Management (14)
Manufacturing (79)
MASH (29)
Medical device (4610)
Medtech (4612)
Mergers & acquisitions (9152)
Metabolic disorders (194)
Multiple sclerosis (33)
NASH (8)
Neurodegenerative disease (29)
Neuropsychiatric disorders (4)
Neuroscience (669)
NextGen: Class of 2025 (2237)
Non-profit (1170)
Northern California (1227)
Now hiring (7)
Obesity (88)
Opinion (57)
Ovarian cancer (33)
Pain (21)
Pancreatic cancer (26)
Parkinson's disease (50)
Partnered (10)
Patents (36)
Patient recruitment (39)
Peanut (48)
People (31313)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase I (7369)
Phase II (10604)
Phase III (9395)
Pipeline (649)
Podcasts (4)
Policy (16)
Postmarket research (1174)
Preclinical (3161)
Press Release (69)
Prostate cancer (43)
Psychedelics (7)
Radiopharmaceuticals (134)
Rare diseases (121)
Real estate (2326)
Recruiting (10)
Regulatory (7886)
Reports (17)
Research institute (821)
Resumes & cover letters (90)
Rett syndrome (4)
RNA editing (2)
RSV (4)
Schizophrenia (33)
Series A (51)
Series B (36)
Service/supplier (2)
Sickle cell disease (20)
Southern California (1035)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (8)
Startups (1522)
State (1)
Stomach cancer (3)
Supply chain (17)
Tariffs (1)
The Weekly (3)
United States (9763)
Vaccines (157)
Venture capitalists (10)
Webinars (5)
Weight loss (40)
Women's health (2)
Worklife (3)
Date
Today (49)
Last 7 days (365)
Last 30 days (1289)
Last 365 days (15390)
2025 (3778)
2024 (16332)
2023 (19053)
2022 (25523)
2021 (27303)
2020 (24467)
2019 (18269)
2018 (13841)
2017 (13863)
2016 (12854)
2015 (16263)
2014 (12488)
2013 (9951)
2012 (10657)
2011 (11230)
2010 (10678)
Location
Africa (274)
Alabama (22)
Alaska (3)
Arizona (80)
Arkansas (1)
Asia (15274)
Australia (2201)
California (2684)
Canada (1105)
China (136)
Colorado (98)
Connecticut (119)
Delaware (69)
Europe (34309)
Florida (298)
Georgia (51)
Idaho (27)
Illinois (164)
India (9)
Indiana (126)
Iowa (2)
Japan (94)
Kansas (27)
Kentucky (11)
Louisiana (6)
Maine (41)
Maryland (328)
Massachusetts (2122)
Michigan (115)
Minnesota (150)
Mississippi (1)
Missouri (35)
Montana (18)
Nebraska (15)
Nevada (28)
New Hampshire (25)
New Jersey (922)
New Mexico (11)
New York (674)
North Carolina (425)
North Dakota (4)
Northern California (1227)
Ohio (86)
Oklahoma (10)
Oregon (13)
Pennsylvania (460)
Puerto Rico (4)
Rhode Island (11)
South America (410)
South Carolina (5)
Southern California (1035)
Tennessee (42)
Texas (327)
Utah (78)
Virginia (50)
Washington D.C. (16)
Washington State (231)
West Virginia (2)
Wisconsin (31)
299,309 Results for "reaction biology corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Reaction Biology Launches Innovative Offering Within Its Kinase Testing Platform and Presents New Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Reaction Biology (“Reaction” or the “Company”), an industry-leading provider of drug discovery and development services, today announced that it will feature its recently launched HotSpot™ ATP-Max KinomeScreen at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 7-10, 2024, in San Diego, California.
April 3, 2024
·
6 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Cytokinetics, Incorporated announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium , May 17th, 2024 at the Mission Bay Conference Center in San Francisco.
May 17, 2024
·
5 min read
Press Releases
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
·
1 min read
Press Releases
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
·
3 min read
Press Releases
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
March 31, 2025
·
4 min read
Press Releases
Sharp Therapeutics Corp. Announces Share Consolidation
January 16, 2025
·
4 min read
Press Releases
ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
March 5, 2025
·
11 min read
Career Advice
Computational Biology, Data Science Hot Areas for Oncology R&D Hiring
As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights on these in-demand roles.
January 2, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.
March 14, 2025
·
4 min read
1 of 29,931
Next
